Clinical Trials Sponsored by Encoded Therapeutics

Total 6337 results

Encoded Therapeutics

Terminated

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies (ENVISION)

Dravet Syndrome

United States, Spain, Australia, United Kingdom
Encoded Therapeutics

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (UK Only)

Dravet Syndrome

United Kingdom
Encoded Therapeutics

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)

Dravet Syndrome

Australia
Encoded Therapeutics

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome (ENDEAVOR)

Dravet Syndrome

United States
Boston Children's Hospital
Encoded Therapeutics

Recruiting

Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome

Dravet Syndrome

United States
Cook Children's Health Care System
Encoded Therapeutics

Recruiting

GABA Biomarkers in Dravet Syndrome

Dravet Syndrome

United States
Encore Medical, L.P.

Enrolling by invitation

The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty

Severe Arthropathy With a Grossly Deficient Rotator Cuff

United States
Encore Medical, L.P.

Completed

Long Term Foundation Knee Study

Total Knee Replacement

United States
Encore Medical, L.P.

Recruiting

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Bimalleolar Ankle Fractures

United States
Encore Medical, L.P.

Completed

2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use (STAR 2 PAS)

Osteoarthritis | Rheumatoid Arthritis | Post Traumatic Arthritis | Primary Arthrosis

United States
Encore Medical, L.P.

Withdrawn

Post-Market Study of the EPIK Knee System (EPIK)

Osteoarthritis | Post Traumatic Degenerative Disease

United States
Encore Medical, L.P.

Completed

Mobile - Bearing Knee Study

Osteoarthritis | Avascular Necrosis | Post-traumatic Arthritis | Inflammatory Tissue Disorder | Secondary Arthritis

United States
Encore Medical, L.P.

Terminated

Foundation Knee Study - Retrospective

Osteoarthritis | Post-traumatic Arthritis | Inflammatory Tissue Disorders | Arthritis Secondary to Other Diseases | Avascular Necrosis of the Femoral Condyles

United States
Encore Medical, L.P.

Terminated

3DKnee™ System vs. the MJS Knee System

Rheumatoid Arthritis | Traumatic Arthritis | Joint Disease Secondary to Osteoarthritis

United States
Encore Medical, L.P.

Completed

Post-Market Study of the 3DKnee™ System

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis | Degenerative Joint Disease

United States
Encore Vision, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia

Presbyopia

United States
Encore Medical, L.P.

Completed

Cementless Alumina-Alumina Total Hip and Hybrid

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis

United States
Encore Medical, L.P.

Completed

Reverse Shoulder Prosthesis Study (RSP)

Rotator Cuff Arthropathy | Failed Total Shoulder | Failed Hemi-arthroplasty

United States
Encore Medical, L.P.

Completed

The 3DKnee™ System: A Post-Market Study

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Varus Deformity | Post Traumatic Arthritis

United States
Encore Medical, L.P.

Terminated

Retrospective Study of the Linear™ Hip

Femoral Fracture | Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Correction of a Functional Deformity

United States
Encore Medical, L.P.

Terminated

Efficacy of the CLP® Hip - Retrospective

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis

United States
Encore Medical, L.P.

Completed

Retrospective Encore Reverse Shoulder Prosthesis Study

Glenohumeral Arthritis | Rotator Cuff Deficiency

United States
OncoMed Pharmaceuticals, Inc.

Terminated

A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian (SIERRA)

Primary Peritoneal Carcinoma

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors

Relapsed or Refractory Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Terminated

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Razor Genomics
Encore Clinical

Recruiting

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States, France, Germany
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer (ALPINE)

Stage IV Pancreatic Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Terminated

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy (PINNACLE)

Stage IV Small Cell Lung Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Relapsed or Refractory Lymphoid Malignancies

United States
OncoMed Pharmaceuticals, Inc.

Completed

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

Cancer Ovaries | Cancer Peritoneal | Cancer, Fallopian Tube

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Refractory Solid Tumors | Advanced Relapsed Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer

Liver Cancer | Hepatocellular Cancer

United States
OncoMed Pharmaceuticals, Inc.

Terminated

A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors

Metastatic Cancer | Locally Advanced Malignant Neoplasm

United States
OncoMed Pharmaceuticals, Inc.

Terminated

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

Metastatic Cancer | Locally Advanced Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer

Ovarian Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors

Advanced Solid Tumor Malignancies

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
More Foundation
Encore Medical, L.P.

Recruiting

Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

Knee Osteoarthritis

United States
Encore Research Inc.
CoolSystems, Inc.

Completed

Cryopneumatic Device After Shoulder Surgeries

Shoulder Injuries | Shoulder Disease

Canada
Ranok Therapeutics (Hangzhou) Co., Ltd.

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Advanced Solid Tumor | DLBCL

United States
OncoMed Pharmaceuticals, Inc.
Bayer

Completed

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

Solid Tumors

United States
Encore Medical, L.P.
DJO Incorporated

Completed

Reverse Shoulder Prosthesis Prospective Multi-Center Study

Shoulder Arthropathy | Rotator Cuff Deficiency | Failed Shoulder Replacement

United States
Encore Medical, L.P.
DJO Incorporated

Terminated

Post-Market Study of the Modular Revision Hip System (MRHS)

Traumatic Fracture | Osteolysis | Aseptic Loosening | Failed Total Hip Implant

United States

Clinical Trials Sponsored by Encoded Therapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations